Bermuda
Every company in the roster headquartered in Bermuda.
Every company in the roster headquartered in Bermuda.
1 of 1 companies
| Company | Pipeline | Most advanced | Next readout | Market cap | Cash & inv. | Runway | R&D / yr |
|---|---|---|---|---|---|---|---|
Kiniksa PharmaceuticalsKNSA · Nasdaq | 1 asset: 1 Ph 2 | vixarelimabPhase 2 · Ulcerative ColitisPartial signal | 25 Aug 2027vixarelimab · Phase 2 | — | $569MSep 2026 | Cash-flow positive | $136M |
Next readout: the earliest estimated primary completion of a trial the company or a partner on the asset runs (ClinicalTrials.gov). Cash shows its balance-sheet month; runway shows a month only when it comes from an earlier report.